TBI-Vision Loss Impacts Vets; Low-Vision Patients May Have Hallucinations
Posted on: Tuesday, 27 October 2009, 15:25 CDT
Oct. 27 scientific program highlights, AAO-PAAO 2009 Meeting
Today's Scientific Program, 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that indicates that Iraq and Afghanistan veterans with vision loss from traumatic brain injury have significantly poorer quality of life than comparable civilian patients, and a Harvard doctor's insights on how to best evaluate and care for low-vision patients who experience vivid visual hallucinations due to Charles Bonnet syndrome.
The AAO-PAAO meeting, the largest, most comprehensive ophthalmic education conference in the world, is in session October 24 through 27 at the Moscone Center, San Francisco.
Quality of Life Worse for Veterans with TBI Vision Loss than for Comparable Civilians
Many young veterans of the Iraq and Afghanistan wars suffer traumatic brain injury (TBI) from exposure to combat explosions. A recent study of TBI's affect on visual function and quality of life in such veterans by Glenn C. Cockerham, MD, Stanford University, and colleagues at the Veterans Administration Palo Alto Department of Ophthalmology, found that most had severe vision problems and poorer quality of life than comparable civilian patients.
Dr. Cockerham, Sonne Lemke, PhD, Catherine Glynn-Milley, CRNO, and Kimberly Cockerham, MD, assessed visual function and occult (not readily detectable) eye injuries in 42 young veterans with blast-related TBI, then evaluated them using two standard quality of life tests, the National Eye Institute Visual Function Questionnaire (VFQ-25) and Neuro-Ophthalmic Supplement (NOS). The veterans' VFQ-25 and NOS scores were compared with accepted norms for patients with similar visual disorders. On the VFQ-25, overall scores were significantly lower for veterans than the reference patient groups; for example, veterans scored lower than norms for patients with glaucoma, multiple sclerosis (MS) and diabetic eye disease. On the NOS the veterans' scores were significantly lower than norms for patients with MS and disease-free adults and were similar to norms for comparable neuro-ophthalmic patients.
The eyes and related tissues are less protected than the head during explosions and are vulnerable to blast forces. A comprehensive eye exam and neuro-ophthalmic evaluation detect occult injuries that may include: structural damage that can lead to glaucoma, retinal and choroidal damage, optic nerve injury, double vision, visual field changes and other disorders.
"The young veterans in our study self-reported compromised visual function in many areas," Dr. Cockerham said. "We found the VFQ-25 and NOS were sensitive to vision loss issues in patients with blast-related TBI. Our future studies will correlate visual function with specific life challenges and determine how these change over time," he added. In September 2009, the Veterans Administration honored Dr. Cockerham and his colleague Greg Goodrich, PhD, with the Olin Teague Award for improving disabled veterans' quality of life.
Who Parked that Double-Decker Bus in My Living Room?
For reasons that remain unclear, about 20 percent of people with neuro-ophthalmic vision loss develop the vivid, recurrent visual hallucinations that characterize Charles Bonnet syndrome (CBS). Physicians and family members need to ask such patients whether they are experiencing hallucinations, as many will not mention it for fear of being labeled mentally incompetent, said Mary Lou Jackson, MD, of the Harvard School of Medicine affiliate Massachusetts Eye and Ear Infirmary. Dr. Jackson is an ophthalmologist who specializes in vision rehabilitation. She said health professionals often incorrectly assume CBS only occurs in those with age-related macular degeneration (AMD). It is true that many AMD patients also have CBS, since AMD is the most common cause of vision loss in the elderly.
In high-definition detail, CBS patients may see wild animals in their closets, familiar or unfamiliar people sitting on their couches, or incongruous but realistic images, like a double-decker bus. Others see odd shapes or indistinct colored areas. A person may find it hard to distinguish the hallucination from reality, especially when the image seems to fit its context. CBS hallucinations do not arise from psychological or cognitive disorders.
Dr. Jackson noted that once patients understand the hallucinations' cause, they often learn to ignore them; medication can be tried if a person continues to be upset, but most patients are not bothered by the images. CBS patients are counseled to keep active, with the lights bright and music on, since hallucinations are more likely during quiet periods. Visual hallucinations have been induced in normal subjects who were blindfolded for several days for research purposes; Dr. Jackson explained that when the brain's occipital cortex is deprived of visual information, a spontaneous release in the form of hallucinations may occur in the visual association area. Vision and the brain researchers are intensely interested in this phenomenon and its relation to CBS.
---
On the Net:
Related Articles
- Some HIV Patients Experience Improved Outlook On Life
- New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life
- Eye Exercises Help Patients Work Out Vision Problems
- The George Washington University School of Public Health and Health Services Aligns Patient, Provider, Business, Labor, Health Insurance and Quality Organizations to Change the Way America Understands and Fights Obesity
- Data Demonstrate Patients on Short Daily Home Hemodialysis Experience Quality of Life Benefits and Reduced Need for Medication
- Dendreon Names Biotech Industry Veteran Mary Coon Vice President of Quality
- Early treatment of macular degeneration with macugen may help patients preserve their vision
- German No-Option Heart Patients, With Only a Two Year Life Expectancy, Celebrate Ten-Year Reunion After Being Treated With Innovative Protein Identical to CVBT's Cardio Vascu-Grow(TM) Currently in U.S. FDA Clinical Trials
- German No-Option Heart Patients, With Only a Two Year Life Expectancy
- What Impact Would Pancreatic Beta-Cell Preservation Have on Life Expectancy, Quality-Adjusted Life Expectancy and Costs of Complications in Patients With Type 2 Diabetes? A Projection Using the CORE Diabetes Model
User Comments (0)

RSS Feeds